CClinicalTrials.gg
CompletedNCT00559663FEAST-CALUpdated Nov 20, 2007

Flavonoid Effect on Activation and Stimulation of Thrombocytes, hsCRP and Lipid Profile

An interventional study of Green tea and 70% dark chocolate in Healthy, sponsored by LifeBridge Health. Completed at 1 site in United States. Open to participants aged 18 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2007-11-20.

Sponsored by LifeBridge Health · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
35
Allocation
Randomized
Ages
18 Years to 55 Years
Sex
All
01

Study summary

The purpose of this study is to compare the effect of dark chocolate with green tea in healthy subjects on clot formation (platelet activity) cholesterol profile and markers of inflammation in two groups.

The first group will be on a regimen of dark chocolate, and the second group will be on a regimen of green tea. Clinical outcomes will be determined after seven days of each treatment and both groups will undergo both treatments subsequently and serve as their own control.

The hypothesis is that both green tea and dark chocolate will reduce platelet activity and reduce LDL, hsCRP and increase HDL.

Read the detailed description

Flavonoids are polyphenolic compounds ubiquitous in fruits and vegetables. They appear in especially high concentrations in the form of flavanols in green tea as well as in cocoa, and are known to have beneficial antioxidant effects in vitro. Flavonoids have been proposed as a key protective dietary component, reducing the risk of coronary heart disease, including the reduction of elevated blood pressure in persons with hypertension and capable of decreasing LDL.

The aim of this prospective single cross-over study is to assess the effect of green tea and dark chocolate consumption on inhibiting platelet activation, Lipid levels, and hsCRP in healthy volunteers.

This research will be done at Sinai Hospital of Baltimore and will include 35 subjects who will be randomized equally between the two groups.

All blood work will be processed at the Sinai Center for Thrombosis Research. Clinical outcomes will be recorded using a standard case report form.

02

Conditions studied

  • Healthy

Keywords

  • Flavonoid
  • hsCRP
  • HDL
  • LDL
  • platelet reactivity
03

In context

Lead sponsor

LifeBridge Health is the lead sponsor of 31 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • non-smokers between the ages of 18-60
  • BMI of 19 to 30

Exclusion criteria

Exclusion Criteria:

  • prior usage of Vitamin C > 1000 mg, Vitamin E > 400IU, Beta Carotene > 1000IU, Vitamin A > 5000IU, Selenium > 200mcg, Folic Acid > 1mg, Aspirin or NSAIDs four weeks prior to study initiation
  • regular ingestion of Flavonoid rich food (EG green tea, dark chocolate, grapes, red wine and others) prior and during the study except what was provided by the study protocol
  • Alcohol or Caffeine consumption 24 prior to blood draws
  • Nursing or pregnant women
  • blood donation up to eight weeks prior to study initiation
  • subjects with coagulation disorders
  • known cardiovascular disease (prior myocardial infarction)
  • drug abuse
  • Diabetes
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
35 participants (actual)

Study arms

  • Active comparator
    GT

    The green tea group is given initially green tea treatment and then after a washout period of four weeks switched to the dark chocolate treatment.

    Dietary Supplement: Green tea

  • Active comparator
    DC

    The dark chocolate group is given initially dark chocolate treatment and then after a washout period of four weeks switched to the green tea treatment.

    Dietary Supplement: 70% dark chocolate

Interventions

  • Dietary supplementGreen tea

    The green tea group consumed first daily one liter of green tea infusate made of 4 bags left in boiling water during 3 minutes. After a four week washout-time they were switched over to the dark chocolate treatment, which included consumption of 3.5 ounces 70% dark chocolate. Blood was drawn before and after each intervention, to check platelet activity with flow cytometry, HDL, LDL and hsCRP Levels

  • Dietary supplement70% dark chocolate

    The dark chocolate group consumed 3.5 ounces 70% dark chocolate per day during a one week period. After a four week washout-time they were given the green tea treatment, which included ingestion of one liter green tea infusate (containing 4 green tea bags). Blood was drawn before and after each intervention, to check platelet activity with flow cytometry, HDL, LDL and hsCRP Levels.

06

What researchers measure

Primary outcomes

  1. The primary outcome was the absolute change in platelet activity measured by Flow Cytometry, HDL, LDL and hsCRP after dark chocolate, respective green tea treatment.

    Time frame: one week of dark chocolate versus one week of green tea ingestion

07

Study locations

1 site
  • Center for Thrombosis Research, Sinai Hospital
    Baltimore, Maryland 21215, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 20, 2007, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00559663
Lead sponsor
LifeBridge Health
First posted
Nov 16, 2007
Start date
Sep 2006
Completion
Apr 2007
Last update
Nov 20, 2007

Study contacts

Paul A Gurbel, MD
principal investigator · Sinai Hospital of Baltimore
Miruais S Hamed, MD
study director · Department of Medicine, Sinai Hospital, Baltimore
Kevin Bliden, BS
study chair · Sinai Center for Thrombosis Research

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2007. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion